These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23136093)

  • 21. The epidemiology of viral hepatitis in children in South Texas: increased prevalence of hepatitis A along the Texas-Mexico border.
    Leach CT; Koo FC; Hilsenbeck SG; Jenson HB
    J Infect Dis; 1999 Aug; 180(2):509-13. PubMed ID: 10395871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Viral hepatitis: vaccination for hepatitis A and B virus].
    Bégué P
    Arch Pediatr; 1999; 6 Suppl 2():186s-189s. PubMed ID: 10370475
    [No Abstract]   [Full Text] [Related]  

  • 23. New vaccine approved for 2 hepatitis viruses.
    AIDS Read; 2001 Jun; 11(6):298. PubMed ID: 11449920
    [No Abstract]   [Full Text] [Related]  

  • 24. [Epidemiologic panorama of viral hepatitis in Mexico].
    Murguía-Martínez P; Kuri-Morales P
    Gac Med Mex; 1997; 133(5):487-92. PubMed ID: 9504079
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis A+B vaccine in elderly persons.
    Wiedermann G
    J Travel Med; 2004; 11(2):130-2. PubMed ID: 15109485
    [No Abstract]   [Full Text] [Related]  

  • 26. Recommendations for protections against viral hepatitis. Centers for Disease Control.
    Conn Med; 1985 Oct; 49(10):687-90. PubMed ID: 4064661
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimal approach to immunization in pediatric solid organ transplantation.
    Danziger-Isakov L; Posfay-Barbe KM
    Pediatr Transplant; 2012 Nov; 16(7):680-3. PubMed ID: 22500495
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vaccines against hepatitis A and B in Chile].
    Valenzuela MT
    Rev Med Chil; 2009 Jun; 137(6):844-51. PubMed ID: 19746289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and epidemiological aspects of imported hepatitis].
    Fujisawa K; Hirakawa J
    Nihon Rinsho; 1989 Jan; 47(1):92-100. PubMed ID: 2498554
    [No Abstract]   [Full Text] [Related]  

  • 31. Universal hepatitis A vaccination in the United States: a call for action.
    Lieberman JM; Word BM; Jacobs RJ; Dagan R; Marchant CD
    Pediatr Infect Dis J; 2008 Apr; 27(4):287-91. PubMed ID: 18316993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study on distribution characteristics of viral hepatitis and preventive strategy in Hangzhou].
    Sun B
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Feb; 11(1):12-5. PubMed ID: 2108804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Viral hepatitis].
    Blond B
    Soins; 2009 Dec; (741):59-60. PubMed ID: 20067051
    [No Abstract]   [Full Text] [Related]  

  • 34. New combined hepatitis A and B vaccine. New vaccine is an adjunct, not an alternative to preventive behaviours.
    Birthistle K; Benbow A
    BMJ; 1998 Apr; 316(7140):1317-8. PubMed ID: 9599053
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Viral hepatitis--trends].
    Manciuc C; Dorobăţ C; Filip-Ciubotaru FM
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):327-31. PubMed ID: 20700962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Difficult to motivate intravenous addicts for vaccination against hepatitis. The campaign in Blekinge was not successful: it reached only 10 percent of the group].
    Eitrem R
    Lakartidningen; 2003 Feb; 100(6):424-6. PubMed ID: 12607435
    [No Abstract]   [Full Text] [Related]  

  • 38. Surveillance for acute viral hepatitis--United States, 2005.
    Wasley A; Miller JT; Finelli L;
    MMWR Surveill Summ; 2007 Mar; 56(3):1-24. PubMed ID: 17363893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?
    Buckley GJ; Strom BL
    Ann Intern Med; 2016 Aug; 165(4):284-5. PubMed ID: 27064885
    [No Abstract]   [Full Text] [Related]  

  • 40. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.